JESSICA MABE: Open Payments
NPI 1750016523 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 87 payments from 22 companies in 2025. Trend: 2023 $1,202 · 2024 $1,164 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $255 |
| AstraZeneca Pharmaceuticals LP | 12 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $153 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Lilly USA, LLC | 2 | $86 |
| ANI Pharmaceuticals, Inc. | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 5 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| Viatris Specialty LLC | 3 | $57 |
Products named: VRAYLAR, Kerendia, REXULTI, TRELEGY ELLIPTA, BREZTRI, PURIFIED CORTROPHIN GEL, AIRSUPRA, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
